Elsevier

European Journal of Cancer

Volume 45, Issue 3, February 2009, Pages 316-317
European Journal of Cancer

Editorial
Adjuvant 5-FU based chemotherapy for colon cancer: Match or miss the mismatch?

https://doi.org/10.1016/j.ejca.2008.10.040Get rights and content

Section snippets

Conflict of interest statement

None declared.

References (5)

There are more references available in the full text version of this article.

Cited by (2)

  • Silica nanorattle with enhanced protein loading: A potential vaccine adjuvant

    2013, Journal of Colloid and Interface Science
    Citation Excerpt :

    Adjuvant has advantages in enhancing vaccine immunity protect effect. Since 1925, first discovered of some other substances (metal salt, lecithin and saponin) can improve the antigen specific immune response by Ramon, all sorts of different material were used as adjuvant [9–11]. However, there were little numbers of clinical cases.

View full text